Diarrhea News and Research

Latest Diarrhea News and Research

Physicians to provide high-quality care, training to medically underserved community

Today, the first class of Texas Children's Global Health Corps will depart Houston for assignment in Africa. This talented team of pediatricians and family doctors will provide medical care and treatment to thousands of children and families affected by serious or life-threatening medical conditions, including sickle cell disease, malaria, tuberculosis, malnutrition, cancer and HIV/AIDS.

30 Jul 2011

Cancer patients should stick to basic sun-protection guidelines, experts say

Summer often brings with it fun in the sun, but for cancer patients it also presents new challenges and the need for additional protection.

30 Jul 2011

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.

29 Jul 2011

Sorrento receives NIAID Phase I STTR grant to develop vaccines against C. difficile infection

Sorrento Therapeutics, Inc. announced today that it has received a Phase I Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

29 Jul 2011

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes.

28 Jul 2011

Curis second quarter net loss increases to $4.9 million

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.

28 Jul 2011

UM researchers unravel genomic code of German E. coli bacteria

A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E. coli bacteria that caused the ongoing deadly outbreak in Germany that began in May 2011.

28 Jul 2011

UNICEF in new African vaccine drive

UNICEF (UN Children's Fund), has launched a massive vaccination campaign across the Horn of Africa to protect 2.5 million children against diseases like measles, which can be deadly for malnourished children. This drive would include a strategy to vaccinate every child in Somalia (under the age of 15) against measles.

27 Jul 2011

FDA accepts peginesatide NDA for anemia associated with CKD

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for peginesatide (formerly known as Hematide™) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.

27 Jul 2011

Extreme heat and rain lead to higher mold count in the Midwest

A record 7 inches of rain combined with the spate of 100-plus-degree days has spawned the highest mold count recorded for the year, just short of an air pollution warning.

27 Jul 2011

VeganZyme supplement may aid in reducing digestive discomfort and symptoms

Every year the American public spends billions of dollars on food and beverages that are toxic to the body and devoid of natural enzymes. These may include processed, microwaved or cooked food, meat, cereal grains, milk, gluten, soy, refined sugar, and more. But are they really getting their money's worth? Not without a little extra help, says Dr. Edward F. Group III, DC, ND, a world-renowned authority on natural medicine and digestive health.

26 Jul 2011

Salmonella outbreak linked to Mexican papayas

Mexican-grown papayas are being recalled after concerns that they may have led to a salmonella outbreak involving 97 people in 23 states. Agromod Produce announced Saturday that it is recalling papayas sold before July 23, which comes in four brands: Blondie, Mañanita, Tastylicious and Yaya.

25 Jul 2011

Fluoride supplements neither safe or effective

Sodium fluoride supplements "have not been found by FDA to be safe or effective," according to the U.S. National Library of Medicine's website, reports the New York State Coalition Opposed to Fluoridation, Inc..

25 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its supplemental Biologics License Application (sBLA) for SIMPONI.

25 Jul 2011

Cholera hits Haiti again

Cholera the bacterial disease that rapidly leads to diarrhea and dehydration and kills millions worldwide ravaged Haiti last fall and has spread quickly to all regions of the Caribbean country. With the rainy season now in progress, clinics across the country are again bustling with seriously ill patients.

24 Jul 2011

Bristol-Myers Squibb announces results of BMS-708163 Phase II study on Alzheimer's

Bristol-Myers Squibb Company today announced the results of a Phase II study evaluating the safety and tolerability of the investigational gamma secretase inhibitor BMS-708163 in patients with mild-to-moderate Alzheimer's disease.

21 Jul 2011

AMAG enters definitive merger agreement with Allos Therapeutics

AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.

21 Jul 2011

Promising results from phase I study of Genentech's GDC-0941 for advanced breast cancer

A new drug targeting the PI3K gene in patients with advanced breast cancer shows promising results in an early phase I investigational study conducted at Virginia G. Piper Cancer at Scottsdale Healthcare, according to a presentation by oncologist Dr. Daniel D. Von Hoff at the 47th annual meeting of the American Society of Clinical Oncology.

21 Jul 2011

Raw eggs are not safe for consumption under any circumstances

A flurry of Internet sites are touting raw egg drinks or shakes as "primal and powerful," with others suggesting uncooked eggs be blended with vanilla or avocado for a tasty, healthy snack and insisting that the connection between raw eggs and salmonella is a myth.

20 Jul 2011